Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASIRIVIMAB\IMDEVIMAB vs CEDIRANIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CASIRIVIMAB\IMDEVIMAB vs CEDIRANIB: Safety Overview

Metric	CASIRIVIMAB\IMDEVIMAB	CEDIRANIB
Total FAERS Reports	4,248	130
Deaths Reported	137	27
Death Rate	3.2%	20.8%
Hospitalizations	1,351	71
Average Patient Age	54.3 yrs	61.2 yrs
% Female Patients	55.4%	62.3%